Monaco Asset Management’s Inovio Pharmaceuticals INO Stock Holding History

Monaco Asset Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$393K	Buy	+2,825	New	+$589K	0.23%	39

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Monaco Asset Management's INO Position: Q3 2020 in Review

Monaco Asset Management opened a new position in Inovio Pharmaceuticals (INO) in Q3 2020: 2,825 shares worth $393K. The stake represents 0.23% of the portfolio and ranks #39 among its holdings.

212 funds tracked by Wall St. Rank hold INO as of Q3 2020.

Monaco Asset Management held 2,825 shares of Inovio Pharmaceuticals worth $393K as of Q3 2020.
Inovio Pharmaceuticals was a new Monaco Asset Management position in Q3 2020.
Inovio Pharmaceuticals made up 0.23% of Monaco Asset Management's portfolio in Q3 2020, its #39 holding.
212 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2020.

Based on Monaco Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.